/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR

Chronicles

The story behind the story

days · browse · Enter similar · o open

Your.MD, which develops “self-care” app Healthily that uses AI to help users check their symptoms before deciding to see a doctor, raises €25M Series A

Mimi Billing / Sifted :

Sifted Mimi Billing

Context & Ripple Effects

Your.MD's €25M Series A lands in the middle of a funding run on AI symptom checkers: K Health raised a $48M Series C for its chat-with-doctors app in March 2020, and Tia Health pulled in a $24M Series A for women's-focused digital care just months before. Healthily sits at the same point in the funnel — assessing symptoms before a user decides whether to see a clinician.

The arc continued after Your.MD's round: Ada Health, the most direct competitor in patient-side symptom assessment, went on to raise a $90M Series B led by Leaps by Bayer in 2021. Capital is clearly converging on whoever owns the first patient touchpoint.

First-order effects

  • Your.MD gets the capital to scale Healthily's self-care triage app, but enters a category where K Health already pairs assessment with doctor chats across 47 US states — pure symptom checking without a care-delivery hook is the thinner offering.

Second-order effects

  • Ada Health's response is visible in the corpus: a much larger round with Bayer's Leaps as lead, pushing rivals toward pharma-strategic backing rather than plain venture money.
  • Investors are pricing the triage app as an acquisition channel — the same logic behind Netherlands-based doctor-communication tools raising from health-focused funds like Heal Capital and Philips' venture arm.

Third-order effects

  • If the funding pattern holds, standalone symptom checkers consolidate into or merge with care delivery — Happify Health's $73M Series D for chronic-condition management via telehealth plus AI assistant shows the model extending beyond triage into ongoing care.

The trend: AI symptom-assessment apps are drawing progressively larger funding rounds as they compete to become the front door to digital primary care.